The global Antivenom market size was valued at USD 987 million in 2022 and is forecast to a readjusted size of USD 1300.5 million by 2029 with a CAGR of 4.0% during review period.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
This report is a detailed and comprehensive analysis for global Antivenom market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antivenom market size and forecasts, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Antivenom market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Antivenom market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Antivenom market shares of main players, shipments in revenue ($ Million), sales quantity (K Vials), and ASP (USD/Vial), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antivenom
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antivenom market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Polyvalent antivenom
Monovalent antivenom
Non-profit Institutions
Hospitals and Clinic
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Antivenom product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antivenom, with price, sales, revenue and global market share of Antivenom from 2018 to 2023.
Chapter 3, the Antivenom competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivenom breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Antivenom market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antivenom.
Chapter 14 and 15, to describe Antivenom sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Antivenom
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antivenom Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polyvalent antivenom
1.3.3 Monovalent antivenom
1.4 Market Analysis by Application
1.4.1 Overview: Global Antivenom Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Non-profit Institutions
1.4.3 Hospitals and Clinic
1.5 Global Antivenom Market Size & Forecast
1.5.1 Global Antivenom Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Antivenom Sales Quantity (2018-2029)
1.5.3 Global Antivenom Average Price (2018-2029)
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Antivenom Product and Services
2.1.4 CSL Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Antivenom Product and Services
2.2.4 Merck Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 BTG
2.3.1 BTG Details
2.3.2 BTG Major Business
2.3.3 BTG Antivenom Product and Services
2.3.4 BTG Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BTG Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Antivenom Product and Services
2.4.4 Pfizer Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Haffkine Bio-Pharmaceutical
2.5.1 Haffkine Bio-Pharmaceutical Details
2.5.2 Haffkine Bio-Pharmaceutical Major Business
2.5.3 Haffkine Bio-Pharmaceutical Antivenom Product and Services
2.5.4 Haffkine Bio-Pharmaceutical Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
2.6 Rare Disease Therapeutics
2.6.1 Rare Disease Therapeutics Details
2.6.2 Rare Disease Therapeutics Major Business
2.6.3 Rare Disease Therapeutics Antivenom Product and Services
2.6.4 Rare Disease Therapeutics Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Rare Disease Therapeutics Recent Developments/Updates
2.7 Flynn Pharma
2.7.1 Flynn Pharma Details
2.7.2 Flynn Pharma Major Business
2.7.3 Flynn Pharma Antivenom Product and Services
2.7.4 Flynn Pharma Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Flynn Pharma Recent Developments/Updates
2.8 Vins Bioproducts
2.8.1 Vins Bioproducts Details
2.8.2 Vins Bioproducts Major Business
2.8.3 Vins Bioproducts Antivenom Product and Services
2.8.4 Vins Bioproducts Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Vins Bioproducts Recent Developments/Updates
2.9 Bharat Serums and Vaccines
2.9.1 Bharat Serums and Vaccines Details
2.9.2 Bharat Serums and Vaccines Major Business
2.9.3 Bharat Serums and Vaccines Antivenom Product and Services
2.9.4 Bharat Serums and Vaccines Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bharat Serums and Vaccines Recent Developments/Updates
2.10 Serum Biotech
2.10.1 Serum Biotech Details
2.10.2 Serum Biotech Major Business
2.10.3 Serum Biotech Antivenom Product and Services
2.10.4 Serum Biotech Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Serum Biotech Recent Developments/Updates
2.11 MicroPharm
2.11.1 MicroPharm Details
2.11.2 MicroPharm Major Business
2.11.3 MicroPharm Antivenom Product and Services
2.11.4 MicroPharm Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MicroPharm Recent Developments/Updates
3 Competitive Environment: Antivenom by Manufacturer
3.1 Global Antivenom Sales Quantity by Manufacturer (2018-2023)
3.2 Global Antivenom Revenue by Manufacturer (2018-2023)
3.3 Global Antivenom Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Antivenom by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Antivenom Manufacturer Market Share in 2022
3.4.2 Top 6 Antivenom Manufacturer Market Share in 2022
3.5 Antivenom Market: Overall Company Footprint Analysis
3.5.1 Antivenom Market: Region Footprint
3.5.2 Antivenom Market: Company Product Type Footprint
3.5.3 Antivenom Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Antivenom Market Size by Region
4.1.1 Global Antivenom Sales Quantity by Region (2018-2029)
4.1.2 Global Antivenom Consumption Value by Region (2018-2029)
4.1.3 Global Antivenom Average Price by Region (2018-2029)
4.2 North America Antivenom Consumption Value (2018-2029)
4.3 Europe Antivenom Consumption Value (2018-2029)
4.4 Asia-Pacific Antivenom Consumption Value (2018-2029)
4.5 South America Antivenom Consumption Value (2018-2029)
4.6 Middle East and Africa Antivenom Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Antivenom Sales Quantity by Type (2018-2029)
5.2 Global Antivenom Consumption Value by Type (2018-2029)
5.3 Global Antivenom Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Antivenom Sales Quantity by Application (2018-2029)
6.2 Global Antivenom Consumption Value by Application (2018-2029)
6.3 Global Antivenom Average Price by Application (2018-2029)
7 North America
7.1 North America Antivenom Sales Quantity by Type (2018-2029)
7.2 North America Antivenom Sales Quantity by Application (2018-2029)
7.3 North America Antivenom Market Size by Country
7.3.1 North America Antivenom Sales Quantity by Country (2018-2029)
7.3.2 North America Antivenom Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Antivenom Sales Quantity by Type (2018-2029)
8.2 Europe Antivenom Sales Quantity by Application (2018-2029)
8.3 Europe Antivenom Market Size by Country
8.3.1 Europe Antivenom Sales Quantity by Country (2018-2029)
8.3.2 Europe Antivenom Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Antivenom Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Antivenom Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Antivenom Market Size by Region
9.3.1 Asia-Pacific Antivenom Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Antivenom Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Antivenom Sales Quantity by Type (2018-2029)
10.2 South America Antivenom Sales Quantity by Application (2018-2029)
10.3 South America Antivenom Market Size by Country
10.3.1 South America Antivenom Sales Quantity by Country (2018-2029)
10.3.2 South America Antivenom Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Antivenom Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Antivenom Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Antivenom Market Size by Country
11.3.1 Middle East & Africa Antivenom Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Antivenom Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Antivenom Market Drivers
12.2 Antivenom Market Restraints
12.3 Antivenom Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Antivenom and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antivenom
13.3 Antivenom Production Process
13.4 Antivenom Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antivenom Typical Distributors
14.3 Antivenom Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Antivenom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antivenom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Antivenom Product and Services
Table 6. CSL Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Antivenom Product and Services
Table 11. Merck Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. BTG Basic Information, Manufacturing Base and Competitors
Table 14. BTG Major Business
Table 15. BTG Antivenom Product and Services
Table 16. BTG Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BTG Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Antivenom Product and Services
Table 21. Pfizer Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Haffkine Bio-Pharmaceutical Major Business
Table 25. Haffkine Bio-Pharmaceutical Antivenom Product and Services
Table 26. Haffkine Bio-Pharmaceutical Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 28. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. Rare Disease Therapeutics Major Business
Table 30. Rare Disease Therapeutics Antivenom Product and Services
Table 31. Rare Disease Therapeutics Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Rare Disease Therapeutics Recent Developments/Updates
Table 33. Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Flynn Pharma Major Business
Table 35. Flynn Pharma Antivenom Product and Services
Table 36. Flynn Pharma Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Flynn Pharma Recent Developments/Updates
Table 38. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table 39. Vins Bioproducts Major Business
Table 40. Vins Bioproducts Antivenom Product and Services
Table 41. Vins Bioproducts Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Vins Bioproducts Recent Developments/Updates
Table 43. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table 44. Bharat Serums and Vaccines Major Business
Table 45. Bharat Serums and Vaccines Antivenom Product and Services
Table 46. Bharat Serums and Vaccines Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Bharat Serums and Vaccines Recent Developments/Updates
Table 48. Serum Biotech Basic Information, Manufacturing Base and Competitors
Table 49. Serum Biotech Major Business
Table 50. Serum Biotech Antivenom Product and Services
Table 51. Serum Biotech Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Serum Biotech Recent Developments/Updates
Table 53. MicroPharm Basic Information, Manufacturing Base and Competitors
Table 54. MicroPharm Major Business
Table 55. MicroPharm Antivenom Product and Services
Table 56. MicroPharm Antivenom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. MicroPharm Recent Developments/Updates
Table 58. Global Antivenom Sales Quantity by Manufacturer (2018-2023) & (K Vials)
Table 59. Global Antivenom Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Antivenom Average Price by Manufacturer (2018-2023) & (USD/Vial)
Table 61. Market Position of Manufacturers in Antivenom, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Antivenom Production Site of Key Manufacturer
Table 63. Antivenom Market: Company Product Type Footprint
Table 64. Antivenom Market: Company Product Application Footprint
Table 65. Antivenom New Market Entrants and Barriers to Market Entry
Table 66. Antivenom Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Antivenom Sales Quantity by Region (2018-2023) & (K Vials)
Table 68. Global Antivenom Sales Quantity by Region (2024-2029) & (K Vials)
Table 69. Global Antivenom Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Antivenom Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Antivenom Average Price by Region (2018-2023) & (USD/Vial)
Table 72. Global Antivenom Average Price by Region (2024-2029) & (USD/Vial)
Table 73. Global Antivenom Sales Quantity by Type (2018-2023) & (K Vials)
Table 74. Global Antivenom Sales Quantity by Type (2024-2029) & (K Vials)
Table 75. Global Antivenom Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Antivenom Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Antivenom Average Price by Type (2018-2023) & (USD/Vial)
Table 78. Global Antivenom Average Price by Type (2024-2029) & (USD/Vial)
Table 79. Global Antivenom Sales Quantity by Application (2018-2023) & (K Vials)
Table 80. Global Antivenom Sales Quantity by Application (2024-2029) & (K Vials)
Table 81. Global Antivenom Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Antivenom Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Antivenom Average Price by Application (2018-2023) & (USD/Vial)
Table 84. Global Antivenom Average Price by Application (2024-2029) & (USD/Vial)
Table 85. North America Antivenom Sales Quantity by Type (2018-2023) & (K Vials)
Table 86. North America Antivenom Sales Quantity by Type (2024-2029) & (K Vials)
Table 87. North America Antivenom Sales Quantity by Application (2018-2023) & (K Vials)
Table 88. North America Antivenom Sales Quantity by Application (2024-2029) & (K Vials)
Table 89. North America Antivenom Sales Quantity by Country (2018-2023) & (K Vials)
Table 90. North America Antivenom Sales Quantity by Country (2024-2029) & (K Vials)
Table 91. North America Antivenom Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Antivenom Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Antivenom Sales Quantity by Type (2018-2023) & (K Vials)
Table 94. Europe Antivenom Sales Quantity by Type (2024-2029) & (K Vials)
Table 95. Europe Antivenom Sales Quantity by Application (2018-2023) & (K Vials)
Table 96. Europe Antivenom Sales Quantity by Application (2024-2029) & (K Vials)
Table 97. Europe Antivenom Sales Quantity by Country (2018-2023) & (K Vials)
Table 98. Europe Antivenom Sales Quantity by Country (2024-2029) & (K Vials)
Table 99. Europe Antivenom Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Antivenom Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Antivenom Sales Quantity by Type (2018-2023) & (K Vials)
Table 102. Asia-Pacific Antivenom Sales Quantity by Type (2024-2029) & (K Vials)
Table 103. Asia-Pacific Antivenom Sales Quantity by Application (2018-2023) & (K Vials)
Table 104. Asia-Pacific Antivenom Sales Quantity by Application (2024-2029) & (K Vials)
Table 105. Asia-Pacific Antivenom Sales Quantity by Region (2018-2023) & (K Vials)
Table 106. Asia-Pacific Antivenom Sales Quantity by Region (2024-2029) & (K Vials)
Table 107. Asia-Pacific Antivenom Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Antivenom Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Antivenom Sales Quantity by Type (2018-2023) & (K Vials)
Table 110. South America Antivenom Sales Quantity by Type (2024-2029) & (K Vials)
Table 111. South America Antivenom Sales Quantity by Application (2018-2023) & (K Vials)
Table 112. South America Antivenom Sales Quantity by Application (2024-2029) & (K Vials)
Table 113. South America Antivenom Sales Quantity by Country (2018-2023) & (K Vials)
Table 114. South America Antivenom Sales Quantity by Country (2024-2029) & (K Vials)
Table 115. South America Antivenom Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Antivenom Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Antivenom Sales Quantity by Type (2018-2023) & (K Vials)
Table 118. Middle East & Africa Antivenom Sales Quantity by Type (2024-2029) & (K Vials)
Table 119. Middle East & Africa Antivenom Sales Quantity by Application (2018-2023) & (K Vials)
Table 120. Middle East & Africa Antivenom Sales Quantity by Application (2024-2029) & (K Vials)
Table 121. Middle East & Africa Antivenom Sales Quantity by Region (2018-2023) & (K Vials)
Table 122. Middle East & Africa Antivenom Sales Quantity by Region (2024-2029) & (K Vials)
Table 123. Middle East & Africa Antivenom Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Antivenom Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Antivenom Raw Material
Table 126. Key Manufacturers of Antivenom Raw Materials
Table 127. Antivenom Typical Distributors
Table 128. Antivenom Typical Customers
List of Figures
Figure 1. Antivenom Picture
Figure 2. Global Antivenom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antivenom Consumption Value Market Share by Type in 2022
Figure 4. Polyvalent antivenom Examples
Figure 5. Monovalent antivenom Examples
Figure 6. Global Antivenom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Antivenom Consumption Value Market Share by Application in 2022
Figure 8. Non-profit Institutions Examples
Figure 9. Hospitals and Clinic Examples
Figure 10. Global Antivenom Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Antivenom Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Antivenom Sales Quantity (2018-2029) & (K Vials)
Figure 13. Global Antivenom Average Price (2018-2029) & (USD/Vial)
Figure 14. Global Antivenom Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Antivenom Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Antivenom by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Antivenom Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Antivenom Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Antivenom Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Antivenom Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Antivenom Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Antivenom Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Antivenom Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Antivenom Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Antivenom Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Antivenom Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Antivenom Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Antivenom Average Price by Type (2018-2029) & (USD/Vial)
Figure 29. Global Antivenom Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Antivenom Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Antivenom Average Price by Application (2018-2029) & (USD/Vial)
Figure 32. North America Antivenom Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Antivenom Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Antivenom Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Antivenom Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Antivenom Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Antivenom Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Antivenom Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Antivenom Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Antivenom Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Antivenom Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Antivenom Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Antivenom Consumption Value Market Share by Region (2018-2029)
Figure 52. China Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Antivenom Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Antivenom Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Antivenom Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Antivenom Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Antivenom Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Antivenom Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Antivenom Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Antivenom Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Antivenom Market Drivers
Figure 73. Antivenom Market Restraints
Figure 74. Antivenom Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Antivenom in 2022
Figure 77. Manufacturing Process Analysis of Antivenom
Figure 78. Antivenom Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
